142 related articles for article (PubMed ID: 15473596)
1. Interstitial pneumonitis in a patient with melanoma treated with the high dose interferon alpha 2b regimen.
Siegelmann-Danieli N; Bardo M; Law A; Fisk D; Bernath A
Isr Med Assoc J; 2004 Oct; 6(10):636-7. PubMed ID: 15473596
[No Abstract] [Full Text] [Related]
2. Interstitial pneumonitis and lung fibrosis during adjuvant treatment of melanoma with interferon alpha according to the Kirkwood schedule.
Puente Vázquez J; Moreno Antón F; Grande Pulido E; López Tarruella-Cobo S; Pérez Segura P; Díaz-Rubio E
Dermatology; 2005; 210(3):247-9. PubMed ID: 15785060
[No Abstract] [Full Text] [Related]
3. Depression in hospitalized patients with malignant melanoma treated with interferon-alpha-2b: primary to induced disorders.
Navinés R; Gómez-Gil E; Puig S; Baeza I; De Pablo J; Martín-Santos R
Eur J Dermatol; 2009; 19(6):611-5. PubMed ID: 19709980
[TBL] [Abstract][Full Text] [Related]
4. Grand mal seizure induced by interferon-alpha-2b.
Kors C; Milling A; Hofmann M; Sterry W; Trefzer U
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):473-4. PubMed ID: 16643159
[No Abstract] [Full Text] [Related]
5. Delayed wound healing following treatment with low-dose interferon alfa-2b for cutaneous melanoma.
Ammoury AF; El Sayed F; Bazex J
Arch Dermatol; 2007 Oct; 143(10):1339-40. PubMed ID: 17938359
[No Abstract] [Full Text] [Related]
6. Urticaria, angioedema and dyspnoea in adjuvant therapy of melanoma with interferon alpha-2b.
Helbig D; Simon JC; Treudler R
Acta Derm Venereol; 2010 May; 90(3):308-9. PubMed ID: 20526557
[No Abstract] [Full Text] [Related]
7. Livedo reticularis associated with interferon alpha therapy in two melanoma patients.
Ruiz-Genao DP; García-F-Villalta MJ; Hernández-Núñez A; Ríos-Buceta L; Fernández-Herrera J; García-Díez A
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):252-4. PubMed ID: 15752306
[TBL] [Abstract][Full Text] [Related]
8. Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma.
Ammoury A; El Sayed F; Farah C; Bazex J
J Am Acad Dermatol; 2008 Mar; 58(3):532-3. PubMed ID: 18280369
[No Abstract] [Full Text] [Related]
9. Livedo reticularis: a side effect of interferon therapy in a pediatric patient with melanoma.
Fox M; Tahan S; Kim CC
Pediatr Dermatol; 2012; 29(3):333-5. PubMed ID: 21575046
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma.
Massaguer S; Sánchez M; Castel T
Eur Radiol; 2004 Sep; 14(9):1716-7. PubMed ID: 14740162
[No Abstract] [Full Text] [Related]
11. Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma.
Nishihori T; Abdo-Matkiwsky M; Fleishman SB; Blum RH
Am J Clin Oncol; 2005 Oct; 28(5):526. PubMed ID: 16199995
[TBL] [Abstract][Full Text] [Related]
12. Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α.
Zonta E; Chiarion V; Zarian H; Peserico A; Alaibac M
Melanoma Res; 2012 Jun; 22(3):284-5. PubMed ID: 22543678
[No Abstract] [Full Text] [Related]
13. Cutaneous sarcoidosis by interferon therapy in a patient with melanoma.
Alonso-Pérez A; Ballestero-Díez M; Fraga J; García-Díez A; Fernández-Herrera J
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1328-9. PubMed ID: 17062055
[No Abstract] [Full Text] [Related]
14. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma.
Navid F; Furman WL; Fleming M; Rao BN; Kovach S; Billups CA; Cain AM; Amonette R; Jenkins JJ; Pappo AS
Cancer; 2005 Feb; 103(4):780-7. PubMed ID: 15660397
[TBL] [Abstract][Full Text] [Related]
15. Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b.
Kiley KE; Gale DM
Clin J Oncol Nurs; 1998 Jan; 2(1):11-6. PubMed ID: 9481251
[TBL] [Abstract][Full Text] [Related]
16. [Vitiligo and morphea: autoimmune cutaneous side effects of interferon treatment].
Martínez-García S; Fernández-Ballesteros MD; Segura-Palacios JM
Actas Dermosifiliogr; 2012 Apr; 103(3):250-1. PubMed ID: 22056259
[No Abstract] [Full Text] [Related]
17. Lipoatrophy associated with interferon alfa adjuvant therapy for melanoma.
Vallés L; González M; Polo I; Enguita AB; Vanaclocha F; Ortiz-Romero PL
Arch Dermatol; 2009 Jan; 145(1):98-9. PubMed ID: 19153363
[No Abstract] [Full Text] [Related]
18. Lichen planus induced by interferon-alpha-2B therapy in a patient with cutaneous malignant melanoma.
Herrera Saval A; Camacho Martínez F
Acta Derm Venereol; 1999 Sep; 79(5):395. PubMed ID: 10494726
[No Abstract] [Full Text] [Related]
19. [Induced interstitial pneumonitis: role of pegylated interferon alpha 2b].
Rocca P; Dumortier J; Tanière P; Duperret S; Vial T; Cottin V; Delafosse B; Scoazec JY; Boillot O
Gastroenterol Clin Biol; 2002 Apr; 26(4):405-8. PubMed ID: 12070414
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
Johnson DM; Hayat SQ; Burton GV
J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
